Eli Lilly and Co
NYSE:LLY

Watchlist Manager
Eli Lilly and Co Logo
Eli Lilly and Co
NYSE:LLY
Watchlist
Price: 786.23 USD -3.15% Market Closed
Market Cap: 747.3B USD
Have any thoughts about
Eli Lilly and Co?
Write Note

Eli Lilly and Co
Accounts Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Eli Lilly and Co
Accounts Receivables Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
ZTS

Competitive Accounts Receivables Analysis
Latest Figures & CAGR of Competitors

Company Accounts Receivables CAGR 3Y CAGR 5Y CAGR 10Y
Eli Lilly and Co
NYSE:LLY
Accounts Receivables
$10.3B
CAGR 3-Years
20%
CAGR 5-Years
13%
CAGR 10-Years
11%
Johnson & Johnson
NYSE:JNJ
Accounts Receivables
$16.2B
CAGR 3-Years
3%
CAGR 5-Years
2%
CAGR 10-Years
3%
Bristol-Myers Squibb Co
NYSE:BMY
Accounts Receivables
$9.7B
CAGR 3-Years
7%
CAGR 5-Years
18%
CAGR 10-Years
18%
Pfizer Inc
NYSE:PFE
Accounts Receivables
$11.4B
CAGR 3-Years
-1%
CAGR 5-Years
4%
CAGR 10-Years
1%
Merck & Co Inc
NYSE:MRK
Accounts Receivables
$11.4B
CAGR 3-Years
10%
CAGR 5-Years
6%
CAGR 10-Years
6%
Zoetis Inc
NYSE:ZTS
Accounts Receivables
$1.4B
CAGR 3-Years
7%
CAGR 5-Years
6%
CAGR 10-Years
3%

See Also

What is Eli Lilly and Co's Accounts Receivables?
Accounts Receivables
10.3B USD

Based on the financial report for Sep 30, 2024, Eli Lilly and Co's Accounts Receivables amounts to 10.3B USD.

What is Eli Lilly and Co's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
11%

Over the last year, the Accounts Receivables growth was 26%. The average annual Accounts Receivables growth rates for Eli Lilly and Co have been 20% over the past three years , 13% over the past five years , and 11% over the past ten years .

Back to Top